There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

The US is Australia’s biggest export market for pharmaceuticals. If the tariffs go ahead, manufacturing could suffer.

The US told the WTO that India's updated dairy certificate remains trade-restrictive and unscientific, raising concerns as ...

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

A son of notorious Mexican drug lord Joaquin “El Chapo” Guzman is expected to plead guilty in a sweeping U.S. drug ...

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

One-fifth of the EU’s exports are heading to the US. Tariffs on the carmaking sector hit the German economy the most, but ...

Here’s how the federal budget reconciliation bill will devastate Alaska’s economy: ...

He called the job “mission impossible.” I recently spoke with a dozen current and former ICE agents and officers about morale ...

Texas State Senator Angela Paxton has filed for divorce from her husband, Republican state Attorney General Ken Paxton, who ...